In the MedicinalProduct resource for FHIR r4 , the legalStatusOfSupply attribute identifies the The legal status of supply of the medicinal product as classified by the regulator
"legalStatusOfSupply":
"identifier": [
{
"system": "http://ema.europa.eu/example/MPID",
"value": "{mpid}"
}
]
"type":
"domain":
"combinedPharmaceuticalDoseForm":
"legalStatusOfSupply":
"additionalMonitoringIndicator":
"specialMeasures":
"paediatricUseIndicator":
"productClassification": [
{
"coding": [
{
"system": "http://ema.europa.eu/example/WHOAnatomicalTherapeuticChemicalATCClassificationSystem",
"code": "WHOAnatomicalTherapeuticChemicalATCClassificationSystem|B01AF02"
}
]
}
]
"marketingStatus":
"pharmaceuticalProduct":
"packagedMedicinalProduct":
"attachedDocument": [
{
"reference": "DocumentReference/example"
}
]
"masterFile": [
{
"reference": "DocumentReference/example"
}
]
"contact":
"clinicalTrial":
"name": [
{
"productName": "Equilidem 2.5 mg film-coated tablets",
"namePart": [
{
"part": "Equilidem",
"type": {
"code": "INV"
}
},
{
"part": "2.5 mg",
"type": {
"code": "STR"
}
},
{
"part": "film-coated tablets",
"type": {
"code": "FRM"
}
}
],
"countryLanguage": [
{
"country": {
"coding": [
{
"system": "http://ema.europa.eu/example/countryCode",
"code": "EU"
}
]
},
"jurisdiction": {
"coding": [
{
"system": "http://ema.europa.eu/example/jurisdictionCode",
"code": "EU"
}
]
},
"language": {
"coding": [
{
"system": "http://ema.europa.eu/example/languageCode",
"code": "EN"
}
]
}
}
]
}
]
"crossReference":
"manufacturingBusinessOperation": [
{
"operationType": {
"coding": [
{
"system": "http://ema.europa.eu/example/manufacturingOperationType",
"code": "Batchrelease"
}
]
},
"authorisationReferenceNumber": {
"system": "http://ema.europa.eu/example/manufacturingAuthorisationReferenceNumber",
"value": "1324TZ"
},
"effectiveDate": "2013-03-15",
"manufacturer": [
{
"reference": "Organization/example"
}
],
"regulator": {
"reference": "Organization/example"
}
}
]
"specialDesignation":